Daniel Meyersfeld

Dr Daniel Meyersfeld completed his PhD in molecular biology at the University of the Witwatersrand, South Africa, in 2005. During his studies, he saw an opportunity to use recent advances in the field of human genetics to improve people’s health and wellness and established DNAlysis Biotechnology in 2007. The company is now recognized as a global leader in the field of biotechnology, with an established practitioner following in South Africa, Scandinavia, Europe, Far East, Middle East and the USA.